Needle-free injection system is an innovative way to introduce
medication into a patient’s body. Unlike the conventional needle
injection system, needle-free injection do not penetrate through the
skin. Needle-free injection system is steadily emerging as an
efficient way to administer the medication with better patient
compliance. There are various advantages offered by needle-free
injection system. This system offers efficiency in administration of
medication with better patient compliance especially for children
(vaccination), geriatric patients (palliative and other care), and
patients with chronic diseases such as diabetes, GI tract disease,
and multiple sclerosis who need daily injection administration.
Self-medication becomes convenient with needle-free injection due to
increased confidence amongst user for self-medication and therefore
it offers better treatment adherence and improved quality of life.
Needle-free injection eliminates needle phobia, as medication is
administered through system such as jet injection system to the skin.
Moreover, needle-free injection system allows drug delivery of even
viscous drug, which is difficult with conventional needle syringe
system.
Ask
For In-Depth Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/1681
Market Dynamics
Needle-free injection system is continuously expanding its market
footprint on account of various factors. Increasing incidence of
needle associated injuries and needle phobia amongst children and
adults is expected to drive growth of needle-free injection system
market. According to a study published in Behavioral Neurology, 2014,
around 3-4 % of the world population faces needle phobia. This
impacts their hospital or clinic visits, as they avoid visiting such
facilities due to fear of exposure to needles. Needle phobia also
impacts the vaccination amongst children, as most of them perceives
injecting vaccine as a painful procedure. According to a study
published in the Clinical Journal of Pain in 2015, there were 12
billion vaccination every year worldwide, most of which required
injecting drug with a needle syringe system. Increasing demand for
vaccines and other biologic products is another factor boosting
growth of the needle-free injection system market. According to the
World Health Organization (WHO) 2018, globally around 86% of infants
are vaccinated against 26 diseases, however, 19.5 million children
are unvaccinated leading to death of 2-3 million children every year.
Chronic disease such as diabetes often needs daily dose of insulin,
which has to be administered through pain needles. This may lead to
lack of adherence to treatment due to lack of confidence to
self-inject insulin. Increasing research on biologics and biosimilar
is another factor expected to fuel growth of the market.
Regional Insights
On the basis of geography, the global needle-free injection system
market is segmented into North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa. North America is a dominant region
in the global needle-free injection system market. This is due to
high prevalence of chronic diseases such as diabetes and cancer.
According to the American Cancer Society, 2018, cancer is the second
leading cause of death after cardio vascular disease in the U.S.
Furthermore, around 1.7 million new cancer cases were reported by
2017 in this region. Rising number of biologic drug approval in the
U.S. is another factor driving growth of needle-free injection system
market. For instance, according to the data published by the U.S. FDA
(United States Food and Drug Administration) in the year 2017, more
than 20 biologic formulation received FDA approval. Asia Pacific is
witnessing high growth in the needle-free injection system market, as
vaccine need is highest in this region. Moreover, this region has
high prevalence of lifestyle disease such as diabetes. According to
the 2017 Diabetes Atlas report, there were over 240 million diabetes
patients in this region.
Competitive Landscape
Some of the key players operating in the market include Antares
Pharma, Inc., Endo International plc, Portal Instruments, Inc.,
Zogenix, PharmaJet, Bioject Medical Technologies Inc., Medical
International Technology, Inc., PenJet Corporation, INJEX Pharma AG,
National Medical Products Inc., Valeritas, Inc., European Pharma
Group, and Crossject SA.
Market Taxonomy
On the basis of Product Type: Prefilled, Fillable
On the basis of Delivery Site: Subcutaneous Injectors,
Intramuscular Injectors, Intradermal Injectors
On the basis of Product Lifecycle: Disposable, Reusable
On the basis of Technology: Jet-based needle free injector,
Spring-based needle free injector, Laser-powered needle free injector
On the basis of Application: Vaccine and other biologic
product delivery, Insulin Delivery, Others
On the basis of End User: Hospitals & Clinics, Home based
care
On the basis of Geography: North America, Latin America,
Europe, Asia Pacific, Middle East, Africa
Browse
Report for More Information @
https://www.coherentmarketinsights.com/ongoing-insight/needle-free-injection-system-market-1681
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment